Showing results (431-440 of 470) with videos related to

Sort By:
Pageof 47
European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD GroupKaitlyn K H Goey, Halfdan Sørbye, Bengt Glimelius, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Alan P Venook, Lynette Cederquist, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 3, 2019
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancerAngela L McCleary-Wheeler, Ryan M Carr, Shanique R Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2017
Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083George Somlo, Paul H Frankel, Banu K Arun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast CancerCynthia X Ma, Ron Bose, Feng Gao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2018
NCCN Guidelines Insights: Colon Cancer, Version 2.2018Al B Benson, Alan P Venook, Mahmoud M Al-Hawary, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 15, 2018
Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Alan P Venook, Mahmoud M Al-Hawary, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 15, 2018
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Alan P Venook, Mahmoud M Al-Hawary, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Rectal Cancer, Version 2.2015Al B Benson, Alan P Venook, Tanios Bekaii-Saab, et al.
NPJ Breast Cancer|February 18, 2022
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancerKirsten G M Aspros, Jodi M Carter, Tanya L Hoskin, et al.
Pageof 47